A Novel Chemical Delivery System Comprising an Ocular Sustained Release Formulation of a 3α, 17α, 21-trihydroxy-5β-pregnan-20-one-BIS-5-Flourouracil Codrug

Author: Howard-Sparks Michelle   Al-Ghananeem Abeer M.   Crooks Peter A.   Pearson Andrew P.  

Publisher: Informa Healthcare

ISSN: 0363-9045

Source: Drug Development and Industrial Pharmacy, Vol.33, Iss.6, 2007-06, pp. : 677-682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content